NewAmsterdam Pharma Company N.V. ( NAMSW) - Stock Earnings
NAMSW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -74.9 million USD | 32000 USD |
| 2026Q1 | -48.4 million USD | 3.0 million USD |
| 2026Q2 | -64.1 million USD | 3.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
NAMSW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -176.9 million USD | 14.1 million USD |
| 2024 | -241.6 million USD | 45.6 million USD |
| 2025 | -203.8 million USD | 22.5 million USD |
| 2026 Est. | — | — |
NAMSW
Price: $16.51
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.2 billion